⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for who grade ii

Every month we try and update this database with for who grade ii cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG)NCT02924038
Glioma
Malignant Gliom...
Astrocytoma, Gr...
Oligodendroglio...
Glioma, Astrocy...
Oligoastrocytom...
IMA950
poly-ICLC
Varlilumab
18 Years - University of California, San Francisco
A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG)NCT02924038
Glioma
Malignant Gliom...
Astrocytoma, Gr...
Oligodendroglio...
Glioma, Astrocy...
Oligoastrocytom...
IMA950
poly-ICLC
Varlilumab
18 Years - University of California, San Francisco
A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG)NCT02924038
Glioma
Malignant Gliom...
Astrocytoma, Gr...
Oligodendroglio...
Glioma, Astrocy...
Oligoastrocytom...
IMA950
poly-ICLC
Varlilumab
18 Years - University of California, San Francisco
Neo-adjuvant Evaluation of Glioma Lysate Vaccines in WHO Grade II GliomaNCT02549833
Oligodendroglio...
Astrocytoma, Gr...
Glioma, Astrocy...
Glioma
Malignant Gliom...
Oligoastrocytom...
GBM6-AD and pol...
GBM6-AD and pol...
18 Years - University of California, San Francisco
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: